2BB score and signals
AN2 Therapeutics, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 11 | Very Weak |
| Quality | 40 | Normal |
| Risk | 35 | Low |
AN2 Therapeutics, Inc. (ANTX) Stock Score & Signals
AN2 Therapeutics, Inc. (ANTX) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 21 out of 100.
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-10 | — | -0.2907 | — | $0.00 |
| 2026-08-06 | — | -0.2754 | — | $0.00 |
| 2026-05-01 | — | -0.2346 | — | $0.00 |
| 2026-04-01 | — | -0.2448 | — | $0.00 |